Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $7.2300 (-2.1%) ($7.2300 - $7.2300) on Wed. Feb. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.86% (three month average) | RSI | 41 | Latest Price | $7.2300(-2.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.8% a day on average for past five trading days. | Weekly Trend | AUTL declines -3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) LIT(13%) XBI(13%) BNDX(12%) SKYY(12%) IBB(11%) | Factors Impacting AUTL price | AUTL will decline at least -2.43% in a week (0% probabilities). USO(-7%) TBT(-7%) UNG(-6%) VIXM(-3%) SHY(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.43% (StdDev 4.86%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.95(-209.96%) | Inflection Point | Yes | Resistance Level | $7.87 | 5 Day Moving Average | $7.21(0.28%) | 10 Day Moving Average | $7.6(-4.87%) | 20 Day Moving Average | $7.87(-8.13%) | To recent high | -39.1% | To recent low | 2.6% | Market Cap | $378m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |